CAS: 1627709-94-7
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | LJI308 REF: AN-AG00ABPQCAS: 1627709-94-7 | ≥98%(HPLC) | To inquire | Tue 21 May 24 |
 | LJI308 REF: TM-T6878CAS: 1627709-94-7 | 99.73% | 45.00 €~502.00 € | Tue 28 May 24 |
 | LJI308 REF: 54-BISN0194CAS: 1627709-94-7 | 98.0 (Typical Value in Batch COA) | 203.00 €~456.00 € | Tue 28 May 24 |
 | LJI308 REF: 3D-CQC70994CAS: 1627709-94-7 | Min. 95% | To inquire | Mon 01 Jul 24 |
LJI308
CAS:1627709-94-7
Formula:
C21H18F2N2O2
Purity:
≥98%(HPLC)
Color and Shape:
Solid
Molecular weight:
368.3766
Ref: AN-AG00ABPQ
| 5mg | 301.00 € | |
| 10mg | 610.00 € | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 21 May 2024
LJI308
CAS:1627709-94-7
LJI308 is a potent, and pan-RSK (p90 ribosomal S6 kinase) inhibitor with IC50 of 6 …
Formula:
C21H18F2N2O2
Purity:
99.73%
Color and Shape:
Solid
Molecular weight:
368.38
- Inhibitors
- MAPK
- PI3K/Akt/mTOR Signaling
- S6 Kinase
- See more categories
- Cancer Research Antibodies
Ref: TM-T6878
| 1mg | 45.00 € | |
| 5mg | 87.00 € | |
| 10mg | 95.00 € | |
| 25mg | 211.00 € | |
| 50mg | 326.00 € | |
| 100mg | 502.00 € | |
| 1ml*10 (DMSO) | 96.00 € |
Estimated delivery in United States, on Tuesday 28 May 2024
LJI308
CAS:1627709-94-7
Formula:
C21H18F2N2O2
Purity:
98.0 (Typical Value in Batch COA)
Color and Shape:
yellow solid
Molecular weight:
368.38g/mol
Ref: 54-BISN0194
| 2mg | 203.00 € | |
| 5mg | 285.00 € | |
| 10mg | 456.00 € |
Estimated delivery in United States, on Tuesday 28 May 2024
LJI308
CAS:1627709-94-7
LJI308 is a novel chemical substance that has been shown to have an effect on …
Formula:
C21H18F2N2O2
Purity:
Min. 95%
Molecular weight:
368.38 g/mol
Ref: 3D-CQC70994
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire |
Estimated delivery in United States, on Monday 1 Jul 2024
